Findings among teens diagnosed with pelvic inflammatory disease in the emergency department
TUESDAY, Aug. 7, 2018 (HealthDay News) — HIV and syphilis screening rates are low among adolescents who are diagnosed with pelvic inflammatory disease (PID) in the emergency department, according to a study published in the August issue of Pediatrics.
Amanda Jichlinski, M.D., from the Children’s National Health System in Washington, D.C., and colleagues used data from the Pediatric Health Information System (2010 to 2015) to identify 10,698 visits to the emergency department by female adolescents who were diagnosed with PID. The frequency of HIV and syphilis screening at these visits was assessed.
The researchers found that 22.0 percent of patients underwent HIV screening, and 27.7 percent underwent syphilis screening. Hospitals varied in screening rates for HIV and syphilis from approximately 3 to 60 percent. Screening was more likely to occur in patients who were non-Hispanic African-American (HIV: adjusted odds ratio [aOR], 1.4; syphilis: aOR, 1.8). Screening was also more likely for non-privately insured patients (HIV: publicly insured aOR, 1.3; uninsured aOR, 1.6; syphilis: publicly insured aOR, 1.4; uninsured aOR, 1.6), and admitted patients (HIV: aOR, 7.0; syphilis: aOR, 4.6), as well as at smaller hospitals (HIV: aOR, 1.4).
“We found low rates of HIV and syphilis screening among adolescents who were diagnosed with PID, with wide variability across hospitals,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance
2009 to 2023 Saw Surge in Probiotic Supplement Use